Evotec Achieves Further Progress in Neuroscience Collaboration with Bristol Myers Squibb

THE COLLABORATION ADDS TWO DRUG DISCOVERY PROJECTS TO THE PORTFOLIO AND DESIGNATES A TARGET-BASED PROGRAMME FOR DEVELOPMENTEVOTEC RECEIVES PAYMENTS IN TOTAL OF US$ 26 M FROM BRISTOL MYERS SQUIBBHAMBURG, GERMANY / ACCESSWIRE / December 16, 2022 / …